LifePoint Health (LPNT) Misses Q3 EPS by 16c, Miss on Revenues; FY17 EPS/Revenue Outlook Below Consensus

LifePoint Health (NASDAQ: LPNT) reported Q3 EPS of $0.80, $0.16 worse than the analyst estimate of $0.96. Revenue for the quarter came in at $1.58 billion versus the consensus estimate of $1.6 billion.

The Company’s revised guidance excludes the fourth quarter operations associated with its recently sold hospital located in Conyers, Georgia, and the impact of the $34.1 million net non-operating gain recognized in the first nine months of 2017, as well as the future impact of items that are non-operational in nature, including items such as, but not limited to, gains or losses related to the transfer of certain of the Company’s home health agencies and hospices to an unconsolidated joint venture partnership, gains or losses on early debt retirements, impairments of long-lived assets and share repurchases. Additionally, guidance excludes the estimated impact of future acquisitions or disposals, if applicable. Finally, this guidance is subject to certain risks including those as set forth in the Company’s “Important Legal Information.”

GUIDANCE:

LifePoint Health sees FY2017 EPS of $3.48-$3.78, versus the consensus of $4.07. LifePoint Health sees FY2017 revenue of $6.335-6.385 billion, versus the consensus of $6.46 billion.

For earnings history and earnings-related data on LifePoint Health (LPNT) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Reading (RDI) Tops Q2 EPS by 4c
• Star Equity Holdings (STRR) Misses Q2 EPS by 8c